Xenon Pharmaceuticals Inc (XENE)
40.54
+0.44
(+1.10%)
USD |
NASDAQ |
Apr 26, 16:00
40.54
0.00 (0.00%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash from Operations (Quarterly): -35.46M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -35.46M |
| September 30, 2023 | -42.23M |
| June 30, 2023 | -33.22M |
| March 31, 2023 | -34.41M |
| December 31, 2022 | -32.73M |
| September 30, 2022 | -30.40M |
| June 30, 2022 | -16.87M |
| March 31, 2022 | -18.43M |
| December 31, 2021 | -20.71M |
| September 30, 2021 | -15.01M |
| June 30, 2021 | -13.08M |
| March 31, 2021 | -20.71M |
| December 31, 2020 | -13.11M |
| September 30, 2020 | -11.15M |
| June 30, 2020 | -10.79M |
| March 31, 2020 | -13.07M |
| December 31, 2019 | 19.79M |
| September 30, 2019 | -7.058M |
| June 30, 2019 | -8.747M |
| March 31, 2019 | -8.696M |
| Date | Value |
|---|---|
| December 31, 2018 | -7.242M |
| September 30, 2018 | -13.72M |
| June 30, 2018 | -5.538M |
| March 31, 2018 | -8.219M |
| December 31, 2017 | -6.838M |
| September 30, 2017 | -8.626M |
| June 30, 2017 | -6.802M |
| March 31, 2017 | -6.46M |
| December 31, 2016 | -4.67M |
| September 30, 2016 | -4.524M |
| June 30, 2016 | -5.429M |
| March 31, 2016 | -4.944M |
| December 31, 2015 | -5.247M |
| September 30, 2015 | -4.885M |
| June 30, 2015 | -2.424M |
| March 31, 2015 | -5.547M |
| December 31, 2014 | -2.951M |
| September 30, 2014 | 6.284M |
| June 30, 2014 | -2.225M |
| March 31, 2014 | -0.842M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-42.23M
Minimum
Sep 2023
19.79M
Maximum
Dec 2019
-18.81M
Average
-16.87M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.31M |
| Edesa Biotech Inc | -1.406M |
| Lexaria Bioscience Corp | -0.6196M |
| ESSA Pharma Inc | -6.787M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -239.73M |
| Cash from Financing (Quarterly) | 324.01M |
| Free Cash Flow | -150.94M |
| Free Cash Flow Per Share (Quarterly) | -0.508 |
| Free Cash Flow Yield | -5.57% |